In a statement last August, departing FDA Commissioner Scott Gottlieb outlined several steps the agency had planned to further address the opioid crisis. Part of
Patient Focused, Data Empowered, Delivery Driven
Biorasi solves the problem of patient access & engagement with data empowered insights and operational excellence, delivering faster, higher quality trials.
- Expert with patient recruitment in complex trials
- Pioneer in clinical trial methods
- Smart data risk-based monitoring
- Trusted resource for trial rescue
Biorasi has worked with some of the leading names and most innovative life sciences startups in pharmaceuticals to improve clinical trial outcomes for sponsor partners, and patients.
Our growth leverages our strong commitment to building true partnerships with our sponsors, as well as our commitment to moving the industry forward through better project management, better processes, better technology, and better people.
Request More Information
Complete the form below to hear form one of our industry experts.
Exceeding CRO Industry Standards
Biorasi provides our global pharmaceutical sponsors with innovative, customized solutions, consistently delivering, highly successful, complex clinical trials, allowing faster trial completion while minimizing their risk of failure.
Biorasi designs and executes trials around the unique needs of each of our sponsors, providing a unique trial management model, unifying teams and their processes with a proven methodology and technology, leveraged on our TALOS™ Ecosystem.
Our mission at Biorasi is to ensure you with highest-quality, optimized clinical trials that accelerates drugs or devices to market while exceeding industry performance standards. Our process and approach is exemplified by our growth with salvaging distressed trials.
Exceeding Industry Standards
Site performance isn’t limited to a database of patients or the time an investigator has been in business. Historical recruiting, communication times, responsiveness, and leveraging business intelligence in our TALOS Ecosystem provide the most realistic model for recruitment.
Protocol Finalized to First Site Selection Visit
Site SelectionLogistics for SSVs are pre-planned and first site selection visits (SSV) occur within 48 hours of obtaining the finalized protocol. Biorasi works with sites and partners during feasibility and protocol development to ensure rapid deployment.
Site InitiationSite terms and contracting are established during the selection process. As the site is selected Biorasi schedules a site initiation visit (SIV) within a month of the SSV, however getting a site operational within three days of the SIV is closer to our norm.
Rollover icons above for more information
Latest News from Biorasi
Advances in stroke management, the first cannabinoid-derived drug approved, new therapeutics for progressive multiple sclerosis, early signs of successful treatment of diabetes and myocardial infarct